Transcriptomics

Dataset Information

0

IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer


ABSTRACT: We identified IGF2BP1 as a marker of the C5 molecular subtype of high-grade ovarian carcinoma (HG-SOC). IGF2BP1 promotes SRC activity and ERK2 expression enhancing the tolerance towards SRC- and MEK-directed inhibitors saracatinib and selumetib. Combination treatment overcomes IGF2BP1-promoted resistance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE147980 | GEO | 2020/08/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA622728 | ENA
2018-03-28 | GSE112371 | GEO
2012-08-02 | E-GEOD-36622 | biostudies-arrayexpress
2017-03-05 | GSE55628 | GEO
2022-12-31 | E-MTAB-11411 | biostudies-arrayexpress
| S-EPMC7951963 | biostudies-literature
2012-08-03 | GSE36622 | GEO
2018-10-10 | GSE116059 | GEO
2019-07-01 | E-MTAB-7018 | biostudies-arrayexpress
2020-06-17 | GSE146803 | GEO